RSS   Newsletter   Contact   Advertise with us

MedPlast appoints Brian D. King as CEO

Share on Twitter Share on LinkedIn
Staff Writer | Tempe, Az., USA | April 10, 2017
Brian D. KingApril 10, 2017, Tempe, Az., USA - MedPlast, a services provider to the medical device industry, announced that it has appointed Brian D. King as chief executive officer and a member of the board of directors, effective May 1, 2017.
Mr. King has more than 25 years of executive operating experience, including ten years with Covidien, a global medical products company now part of Medtronic plc.

During his tenure with Covidien, Mr. King was promoted to positions of increasing responsibility, including president of Asia, senior vice president of corporate operations and group president of the company's emerging markets business.

He also served as chief transformation officer for the DePuy Synthes business of Johnson & Johnson.

Earlier in his career, he served in executive positions with oncology pharmaceutical enterprises and as a consultant with McKinsey & Co.

Mr. King is a graduate of the U.S. Naval Academy and holds a master's degree in civil engineering from the Pennsylvania State University and a master's in business administration from Harvard Business School.